{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:08:38Z","timestamp":1788638918406,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fluoroquinolones are a group of antibiotics used in urinary tract infections. Unfortunately, resistance to this group of drugs is currently growing. The combined action of fluoroquinolones and other antibacterial and anti-biofilm substances may extend the use of this therapeutic option by clinicians. The aim of the study was to determine the effect of selected fluoroquinolones and therapeutic concentrations of ascorbic acid and rutoside on biofilm formation by\n                      <jats:italic>Proteus mirabilis<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      The study included 15 strains of\n                      <jats:italic>P. mirabilis<\/jats:italic>\n                      isolated from urinary tract infections in patients of the University Hospital No. 1 dr A. Jurasz in Bydgoszcz (Poland). The metabolic activity of the biofilm treated with 0.4\u00a0mg\/ml ascorbic acid, 0.02\u00a0\u00b5g\/ml rutoside and chemotherapeutic agents (ciprofloxacin, norfloxacin) in the concentration range of 0.125\u20134.0 MIC (minimum inhibitory concentration) was assessed spectrophotometrically.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Both ciprofloxacin and norfloxacin inhibited biofilm formation by the tested strains. The biofilm reduction rate was correlated with the increasing concentration of antibiotic used. No synergism in fluoroquinolones with ascorbic acid, rutoside or both was found. The ascorbic acid and rutoside combination, however, significantly decreased biofilm production.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our research proves a beneficial impact of ascorbic acid with rutoside supplementation on biofilm of\n                      <jats:italic>P. mirabilis<\/jats:italic>\n                      strains causing urinary tract infections.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-022-00515-5","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T01:02:49Z","timestamp":1654131769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effect of fluoroquinolones and antioxidans on biofilm formation by Proteus mirabilis strains"],"prefix":"10.1186","volume":"21","author":[{"given":"Jana","family":"Przekwas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"G\u0119balski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kwieci\u0144ska-Pir\u00f3g","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Wiktorczyk-Kapischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wa\u0142ecka-Zacharska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Gospodarek-Komkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-864X","authenticated-orcid":false,"given":"Krzysztof","family":"Skowron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"issue":"4","key":"515_CR1","first-page":"305","volume":"53","author":"M Op\u0119chowska","year":"2014","unstructured":"Op\u0119chowska M, Bielecki S. Rola alternatywnych czynnik\u00f3w sigma S (\u03c3S ) I sigma B (\u03c3B) w odpowiedzi kom\u00f3rki bakteryjnej na stres oraz ich regulacja. Adv Microbiol. 2014;53(4):305\u201317.","journal-title":"Adv Microbiol"},{"issue":"10","key":"515_CR2","first-page":"172","volume":"2","author":"NMA Abdallah","year":"2011","unstructured":"Abdallah NMA, Elsayed SB, Yassin MM, El-Gohary M, El-Gohary GM. Biofilm forming bacteria isolated from urinary tract infection, realtion to cathaterization and susceptibility to antibiotics. Int J Biotechnol Mol Biol Res. 2011;2(10):172\u20138.","journal-title":"Int J Biotechnol Mol Biol Res"},{"issue":"76","key":"515_CR3","first-page":"40","volume":"1","author":"K Czaczyk","year":"2007","unstructured":"Czaczyk K, Myszka K. Mechanizmy warunkuj\u0105ce oporno\u015b\u0107 biofilm\u00f3w bakteryjnych na czynniki antymikrobiologiczne. Biotechnologia. 2007;1(76):40\u201352.","journal-title":"Biotechnologia"},{"issue":"20","key":"515_CR4","doi-asserted-by":"publisher","first-page":"e00249","DOI":"10.1128\/JB.00249-18","volume":"200","author":"M Ayrapetyan","year":"2018","unstructured":"Ayrapetyan M, Williams T, Oliver JD. Relationship between the viable but nonculturable state and antibiotic persister cells. J Bacteriol. 2018;200(20):e00249-e318. https:\/\/doi.org\/10.1128\/JB.00249-18.","journal-title":"J Bacteriol"},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","volume":"15","author":"H Koo","year":"2017","unstructured":"Koo H, Allan RN, Howlin RP, Hall-Stoodley L, Stoodley P. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rewievs Microbiol. 2017;15:740\u201355. https:\/\/doi.org\/10.1038\/nrmicro.2017.99.","journal-title":"Nat Rewievs Microbiol"},{"issue":"1","key":"515_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0966-842x(00)01913-2","volume":"9","author":"TF Mah","year":"2001","unstructured":"Mah TF, O\u2019Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1):34\u20139. https:\/\/doi.org\/10.1016\/s0966-842x(00)01913-2.","journal-title":"Trends Microbiol"},{"key":"515_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2221-1691(12)60494-8","author":"A Balasubramanian","year":"2012","unstructured":"Balasubramanian A, Singh AR, Alagumuthu G. Isolation and identification of microbes from biofilm of urinary catheters and antimicrobial susceptibility evaluation. Asian Pac J Trop Biomed. 2012. https:\/\/doi.org\/10.1016\/S2221-1691(12)60494-8.","journal-title":"Asian Pac J Trop Biomed"},{"key":"515_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0017-2013","author":"MM Pearsen","year":"2015","unstructured":"Pearsen MM, Schaffer JN. Proteus mirabilis and urinary tract infections. Microbiol Spectr. 2015. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0017-2013.","journal-title":"Microbiol Spectr"},{"issue":"10","key":"515_CR9","doi-asserted-by":"publisher","first-page":"e0141711","DOI":"10.1371\/journal.pone.0141711","volume":"10","author":"SA Wilks","year":"2015","unstructured":"Wilks SA, Fader MJ, Keevil CW. Novel insights into the proteus mirabilis crystalline biofilm using real-time imaging. PLoS ONE. 2015;10(10):e0141711. https:\/\/doi.org\/10.1371\/journal.pone.0141711.","journal-title":"PLoS ONE"},{"key":"515_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020414","author":"A Fusco","year":"2017","unstructured":"Fusco A, Coretti L, Savio V, Buommino E, Lembo F, Donnarumm G. biofilm formation and immunomodulatory activity of Proteus mirabilis clinically isolated strains. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18020414.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"515_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jmii.2011.11.007","volume":"45","author":"C-Y Chen","year":"2012","unstructured":"Chen C-Y, Chen Y-H, Lu P-L, Lin W-R, Chen T-C, Lin C-Y. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes. J Microbiol Immunol Infect. 2012;45(3):228\u201336. https:\/\/doi.org\/10.1016\/j.jmii.2011.11.007.","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"515_CR12","doi-asserted-by":"publisher","first-page":"1800141","DOI":"10.1002\/ardp.201800141","volume":"351","author":"HAA Ezelarab","year":"2018","unstructured":"Ezelarab HAA, Abbas SH, Hassan HA, Abuo-Rahma GEDA. Recent updates of fluoroquinolones as antibacterial agents. Arch Pharm (Weinheim). 2018;351(9):1800141. https:\/\/doi.org\/10.1002\/ardp.201800141.","journal-title":"Arch Pharm (Weinheim)"},{"issue":"1","key":"515_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/AAC.02299-15","volume":"60","author":"MJ Ferr\u00e1ndiz","year":"2016","unstructured":"Ferr\u00e1ndiz MJ, Mart\u00edn-Galiano AJ, Arnanz C, Zimmerman T, de la Campa AG. Reactive oxygen species contribute to the bactericidal effects of the fluoroquinolone moxifloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2016;60(1):409\u201317. https:\/\/doi.org\/10.1128\/AAC.02299-15.","journal-title":"Antimicrob Agents Chemother"},{"key":"515_CR14","first-page":"343","volume":"58","author":"M Konopacka","year":"2004","unstructured":"Konopacka M. Role of vitamin C in oxidative DNA damage. Post\u0119py Hig Med Do\u015bw. 2004;58:343\u20138.","journal-title":"Post\u0119py Hig Med Do\u015bw"},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3389\/fmicb.2017.02599","volume":"8","author":"S Pandit","year":"2017","unstructured":"Pandit S, Ravikumar V, Abdel-Haleem AM, et al. Low concentrations of vitamin C reduce the synthesis of extracellular polymers and destabilize bacterial biofilms. Front Microbiol. 2017;8:2599. https:\/\/doi.org\/10.3389\/fmicb.2017.02599.","journal-title":"Front Microbiol"},{"key":"515_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnw282","author":"K Syal","year":"2017","unstructured":"Syal K, Bhardwaj N, Chatterji D. Vitamin C targets (p)ppGpp synthesis leading to stalling of long-term survival and biofilm formation in Mycobacterium smegmatis. FEMS Microbiol Lett. 2017. https:\/\/doi.org\/10.1093\/femsle\/fnw282.","journal-title":"FEMS Microbiol Lett"},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-981-13-3065-0_22","volume":"1112","author":"K Syal","year":"2018","unstructured":"Syal K, Chatterji D. Vitamin C: a natural inhibitor of cell wall functions and stress response in Mycobacteria. Adv Exp Med Biol. 2018;1112:321\u201332. https:\/\/doi.org\/10.1007\/978-981-13-3065-0_22.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"515_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.22038\/IJBMS.2018.20714.5398","volume":"21","author":"Z Ali Mirani","year":"2018","unstructured":"Ali Mirani Z, Khan MN, Siddiqui A, et al. Ascorbic acid augments colony spreading by reducing biofilm formation of methicillin-resistant Staphylococcus aureus. Iran J Basic Med Sci. 2018;21(2):175\u201380. https:\/\/doi.org\/10.22038\/IJBMS.2018.20714.5398.","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"515_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s13197-019-04134-5","volume":"57","author":"HRA Silva","year":"2020","unstructured":"Silva HRA, de Souza GM, Fernandes JD, Constantino CJL, Winkelstroter LK. Unravelling the effects of the food components ascorbic acid and capsaicin as a novel anti-biofilm agent against Escherichia coli. J Food Sci Technol. 2020;57(3):1013\u201320. https:\/\/doi.org\/10.1007\/s13197-019-04134-5.","journal-title":"J Food Sci Technol"},{"issue":"1","key":"515_CR20","first-page":"9","volume":"43","author":"H Puzanowska-Tarasiewicz","year":"2010","unstructured":"Puzanowska-Tarasiewicz H, Ku\u017amicka L, Tarasiewicz M. Antioxidants and reactive oxygen species. Bromatol Chem Toksykol. 2010;43(1):9\u201314.","journal-title":"Bromatol Chem Toksykol"},{"issue":"2","key":"515_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jsps.2016.04.025","volume":"25","author":"A Ganeshpurkar","year":"2017","unstructured":"Ganeshpurkar A, Saluja AK. The Pharmacological Potential of Rutin. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2017;25(2):149\u201364. https:\/\/doi.org\/10.1016\/j.jsps.2016.04.025.","journal-title":"Saudi Pharm J SPJ Off Publ Saudi Pharm Soc"},{"issue":"5","key":"515_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1128\/AAC.41.5.992","volume":"41","author":"FX Bernard","year":"1997","unstructured":"Bernard FX, Sable S, Cameron B, Provost J. glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob Agents Chemother. 1997;41(5):992\u20138. https:\/\/doi.org\/10.1128\/AAC.41.5.992.","journal-title":"Antimicrob Agents Chemother"},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.micpath.2018.04.007","volume":"119","author":"L-Y Peng","year":"2018","unstructured":"Peng L-Y, et al. Rutin inhibits quorum sensing, biofilm formation and virulence genes in avian pathogenic Escherichia coli. Microb Pathog. 2018;119:54\u20139. https:\/\/doi.org\/10.1016\/j.micpath.2018.04.007.","journal-title":"Microb Pathog"},{"issue":"18","key":"515_CR24","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1080\/07391102.2019.1704884","volume":"38","author":"R Jhanji","year":"2020","unstructured":"Jhanji R, Bhati V, Singh A, Kumar A. Phytomolecules against bacterial biofilm and efflux pump: an in silico and in vitro study. J Biomol Struct Dyn. 2020;38(18):5500\u201312. https:\/\/doi.org\/10.1080\/07391102.2019.1704884.","journal-title":"J Biomol Struct Dyn"},{"key":"515_CR25","first-page":"7","volume":"70","author":"J Samaszko-Fiertek","year":"2016","unstructured":"Samaszko-Fiertek J, Roguszczak P, Dmochowska B, \u015alusarz R, Madaj J. Rutin\u2014structure and properties. Wiad Chem. 2016;70:7\u20138.","journal-title":"Wiad Chem"},{"key":"515_CR26","unstructured":"Hryniewicz W, Sulikowska A, Szczypa K, Krzyszto\u0144-Russjan J, Gniadkowski M. Reccomendations for susceptibility testing to antimicrobial agents of selected bacterial species. Krajowy O\u015brodek Referencyjny, d\/s Lekowra\u017cliwo\u015bci Drobnoustroj\u00f3w; Centralne Laboratorium Surowic i Szczepionek w Warszawie. 2009."},{"key":"515_CR27","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, 2021. http:\/\/www.eucast.org. Accessed 30 August 2021."},{"key":"515_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1120009X.2017.1380397","volume":"29","author":"E Concia","year":"2017","unstructured":"Concia E, Bragantini D, Mazzaferri F. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. J Chemother. 2017;29:19\u201328. https:\/\/doi.org\/10.1080\/1120009X.2017.1380397.","journal-title":"J Chemother"},{"key":"515_CR29","unstructured":"Jamil RT, Foris LA. Snowden J. Proteus Mirabilis Infections. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK442017\/."},{"key":"515_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2334-14-486","volume":"14","author":"JT Wang","year":"2014","unstructured":"Wang JT, Chen PC, Chang SC, et al. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. BMC Infect Dis. 2014;14:486. https:\/\/doi.org\/10.1186\/1471-2334-14-486.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"515_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1128\/AAC.48.1.151-160.2004","volume":"48","author":"GD Bonaventura","year":"2004","unstructured":"Bonaventura GD, Spedicato I, D\u2019Antonio D, Robuffo I, Piccolomini R. Biofilm Formation by Stenotrophomonas maltophilia: Modulation by Quinolones, Trimethoprim-Sulfamethoxazole, and Ceftazidime. Antimicrob Agents Chemother. 2004;48(1):151\u201360. https:\/\/doi.org\/10.1128\/AAC.48.1.151-160.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"515_CR32","doi-asserted-by":"publisher","first-page":"29701","DOI":"10.1038\/srep29701","volume":"6","author":"A Wang","year":"2016","unstructured":"Wang A, Wang Q, Kudinha T, Xiao S, Zhuo C. Effects of Fluoroquinolones and Azithromycin on Biofilm Formation of Stenotrophomonas maltophilia. Sci Rep. 2016;6(1):29701. https:\/\/doi.org\/10.1038\/srep29701.","journal-title":"Sci Rep"},{"issue":"4","key":"515_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijantimicag.2014.11.008","volume":"45","author":"H Saini","year":"2015","unstructured":"Saini H, Chhibber S, Harjai K. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. Int J Antimicrob Agents. 2015;45(4):359\u201367. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.11.008.","journal-title":"Int J Antimicrob Agents"},{"key":"515_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens8010012","author":"MM Masadeh","year":"2019","unstructured":"Masadeh MM, Alzoubi KH, Ahmed WS, Magaji AS. In Vitro comparison of antibacterial and antibiofilm activities of selected fluoroquinolones against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Pathogens. 2019. https:\/\/doi.org\/10.3390\/pathogens8010012.","journal-title":"Pathogens"},{"key":"515_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fmicb.2019.00040","volume":"10","author":"KB Martins","year":"2019","unstructured":"Martins KB, Ferreira AM, Pereira VC, Pinheiro L, de Oliveira A, et al. In vitro Effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus saprophyticus isolated from patients with urinary tract infections. Front Microbiol. 2019;10:40. https:\/\/doi.org\/10.3389\/fmicb.2019.00040.","journal-title":"Front Microbiol"},{"issue":"1","key":"515_CR36","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1080\/02656736.2021.1943546","volume":"38","author":"D Gazel","year":"2021","unstructured":"Gazel D, Demirbakan H, Erinmez M. In vitro activity of hyperthermia on swarming motility and antimicrobial susceptibility profiles of Proteus mirabilis isolates. Int J Hyperthermia. 2021;38(1):1002\u201312. https:\/\/doi.org\/10.1080\/02656736.2021.1943546.","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"515_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid0901.020277","volume":"9","author":"WM Scheld","year":"2003","unstructured":"Scheld WM. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis. 2003;9(1):1.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"515_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/archinte.159.1.53","volume":"159","author":"G Mombelli","year":"1999","unstructured":"Mombelli G, Pezzoli R, Pinoja-Lutz G, Monotti R, Marone C, Franciolli M. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med. 1999;159(1):53\u20138. https:\/\/doi.org\/10.1001\/archinte.159.1.53.","journal-title":"Arch Intern Med"},{"issue":"4","key":"515_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2165\/00003088-200746040-00003","volume":"46","author":"FME Wagenlehner","year":"2007","unstructured":"Wagenlehner FME, Weidner W, Naber KG. Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis. Clin Pharmacokinet. 2007;46(4):291\u2013305. https:\/\/doi.org\/10.2165\/00003088-200746040-00003.","journal-title":"Clin Pharmacokinet"},{"key":"515_CR40","unstructured":"European Association of Urology. EAU Gudelines on Urological Infections. https:\/\/uroweb.org\/guideline\/urological-infections\/ Accessed 30 August 2021."},{"issue":"3","key":"515_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/iju.13493","volume":"25","author":"HS Choe","year":"2018","unstructured":"Choe HS, Lee SJ, Yang SS, Hamasuna R, Yamamoto S, Cho YH, Matsumoto T. Committee for Development of the UAA-AAUS. Guidelines for UTI and STI. Summary of the UAA-AAUS guidelines for urinary tract infections. Int J Urol. 2018;25(3):175\u201385. https:\/\/doi.org\/10.1111\/iju.13493.","journal-title":"Int J Urol"},{"issue":"4","key":"515_CR42","first-page":"339","volume":"36","author":"G \u00c7elen","year":"2008","unstructured":"\u00c7elen G, \u00d6zkan S, Ayhan F. The phenolic compounds from hypericum perforatum and their antimicrobial activities. Hacet J Biol Chem. 2008;36(4):339\u201345.","journal-title":"Hacet J Biol Chem"},{"key":"515_CR43","doi-asserted-by":"publisher","unstructured":"Ciocan D, Ioan B. Plant Products as antimicrobial agents. Analele Tiiocifice Ale Universitatii Alexandru Ioan Cuza Din Iasi, Sectiunea II A: Genetica si Biologie Moleculara. 2007;8. https:\/\/doi.org\/10.3109\/9781420019919-17.","DOI":"10.3109\/9781420019919-17"},{"issue":"11","key":"515_CR44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/apm.12083","volume":"121","author":"V Plyuta","year":"2013","unstructured":"Plyuta V, Zaitseva J, Lobakova E, Zagoskina N, Kuznetsov A, Khmel I. Effect of plant phenolic compounds on biofilm formation by Pseudomonas aeruginosa. APMIS. 2013;121(11):1073\u201381. https:\/\/doi.org\/10.1111\/apm.12083.","journal-title":"APMIS"},{"key":"515_CR45","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.indcrop.2015.05.067","volume":"74","author":"N Martins","year":"2015","unstructured":"Martins N, Barros L, Henriques M, Silva S, Ferreira ICFR. Activity of phenolic compounds from plant origin against Candida species. Ind Crops Prod. 2015;74:648\u201370. https:\/\/doi.org\/10.1016\/j.indcrop.2015.05.067.","journal-title":"Ind Crops Prod"},{"key":"515_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fphar.2017.00379","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S, Wang C, Gao L, et al. Rutin inhibits Streptococcus suis biofilm formation by affecting CPS biosynthesis. Front Pharmacol. 2017;8:379. https:\/\/doi.org\/10.3389\/fphar.2017.00379.","journal-title":"Front Pharmacol"},{"issue":"4","key":"515_CR47","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1365-2672.2001.01271.x","volume":"90","author":"R Puupponen-Pimi\u00e4","year":"2001","unstructured":"Puupponen-Pimi\u00e4 R, Nohynek L, Meier C, K\u00e4hk\u00f6nen M, Heinonen M, Hopia A, Oksman-Caldentey KM. Antimicrobial properties of phenolic compounds from berries. J Appl Microbiol. 2001;90(4):494\u2013507. https:\/\/doi.org\/10.1046\/j.1365-2672.2001.01271.x.","journal-title":"J Appl Microbiol"},{"issue":"2","key":"515_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/medicines4020025","volume":"4","author":"S Mac\u00e9","year":"2017","unstructured":"Mac\u00e9 S, Truelstrup Hansen L, Rupasinghe HPV. Anti-bacterial activity of phenolic compounds against Streptococcus pyogenes. Medicines. 2017;4(2):25. https:\/\/doi.org\/10.3390\/medicines4020025.","journal-title":"Medicines"},{"issue":"2","key":"515_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172273","volume":"12","author":"L Sanhueza","year":"2017","unstructured":"Sanhueza L, Melo R, Montero R, Maisey K, Mendoza L, Wilkens M. Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli. PLoS ONE. 2017;12(2): e0172273. https:\/\/doi.org\/10.1371\/journal.pone.0172273.","journal-title":"PLoS ONE"},{"issue":"13","key":"515_CR50","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1002\/jsfa.6156","volume":"93","author":"D Stojkovi\u0107","year":"2013","unstructured":"Stojkovi\u0107 D, Petrovi\u0107 J, Sokovi\u0107 M, Glamo\u010dlija J, Kuki\u0107-Markovi\u0107 J, Petrovi\u0107 S. In situ antioxidant and antimicrobial activities of naturally occurring caffeic acid, p -coumaric acid and rutin, using food systems: In situ antioxidant and antimicrobial activities of naturally occurring caffeic acid. J Sci Food Agric. 2013;93(13):3205\u20138. https:\/\/doi.org\/10.1002\/jsfa.6156.","journal-title":"J Sci Food Agric"},{"issue":"1","key":"515_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12223-008-0003-4","volume":"53","author":"MA Alvarez","year":"2008","unstructured":"Alvarez MA, Debattista NB, Pappano NB. Antimicrobial activity and synergism of some substituted flavonoids. Folia Microbiol. 2008;53(1):23\u20138. https:\/\/doi.org\/10.1007\/s12223-008-0003-4.","journal-title":"Folia Microbiol"},{"issue":"5","key":"515_CR52","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1271\/bbb.66.1009","volume":"66","author":"H Arima","year":"2002","unstructured":"Arima H, Ashida H, Danno G. Rutin-enhanced Antibacterial Activities of Flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci Biotechnol Biochem. 2002;66(5):1009\u201314. https:\/\/doi.org\/10.1271\/bbb.66.1009.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"515_CR53","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.foodcont.2018.02.044","volume":"90","author":"S Deepika","year":"2018","unstructured":"Deepika S, Ramar T, Periasamy S, Sridhar A. Combined effect of a natural flavonoid rutin from Citrus sinensis and conventional antibiotic gentamicin on Pseudomonas aeruginosa biofilm formation. Food Control. 2018;90(1):282\u201394.","journal-title":"Food Control"},{"issue":"1","key":"515_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12906-015-0580-0","volume":"15","author":"MU Amin","year":"2015","unstructured":"Amin MU, Khurram M, Khattak B, Khan J. Antibiotic additive and synergistic action of rutin, morin and quercetin against methicillin resistant Staphylococcus aureus. BMC Complement Altern Med. 2015;15(1):59. https:\/\/doi.org\/10.1186\/s12906-015-0580-0.","journal-title":"BMC Complement Altern Med"},{"issue":"4","key":"515_CR55","first-page":"419","volume":"61","author":"K Janda","year":"2015","unstructured":"Janda K, Kasprzak M, Wolska J. Vitamin C\u2014structure, properties, occurrence and functions. Pomeranian J Life Sci. 2015;61(4):419\u201325.","journal-title":"Pomeranian J Life Sci"},{"key":"515_CR56","first-page":"747","volume":"71","author":"J Guz","year":"2017","unstructured":"Guz J, Oli\u0144ski R. The role of vitamin C in epigenetic regulation. Post\u0119py Hig Med Do\u015bw. 2017;71:747\u201360.","journal-title":"Post\u0119py Hig Med Do\u015bw"},{"key":"515_CR57","first-page":"185","volume":"61","author":"J Guz","year":"2007","unstructured":"Guz J, Dziaman T, Szpila A. Do antioxidant vitamins influence carcinogenesis? Post\u0119py Hig Med Do\u015bw. 2007;61:185\u201398.","journal-title":"Post\u0119py Hig Med Do\u015bw"},{"key":"515_CR58","doi-asserted-by":"publisher","DOI":"10.4172\/2329-8731.1000166","author":"S Afzal","year":"2017","unstructured":"Afzal S, Ashraf M, Bukhsh A, Akhtar S, Rasheed AD. Efficacy of anti-microbial agents with ascorbic acid in catheter associated urinary tract infection. J Anc Dis Prev Remedies. 2017. https:\/\/doi.org\/10.4172\/2329-8731.1000166.","journal-title":"J Anc Dis Prev Remedies"},{"issue":"4","key":"515_CR59","first-page":"349","volume":"76","author":"K Ma\u0107kowiak","year":"2007","unstructured":"Ma\u0107kowiak K, Torli\u0144ski L. Contemporary view on the role of vitamin C in human physiology and pathology. Now Lek. 2007;76(4):349\u201356.","journal-title":"Now Lek"},{"key":"515_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.16926\/tiib.2015.03.07","volume":"3","author":"R Musieli\u0144ska","year":"2015","unstructured":"Musieli\u0144ska R, Bus B. An overview of selected antioxidants in the aspect of safety their their application D\u0142ugosza W Cz\u0119stochowie Tech. Pr Nauk Akad Im Jana D\u0142ugosza W Cz\u0119stochowie Tech Inform In\u017c Bezpiecze\u0144stwa. 2015;3:93\u2013112. https:\/\/doi.org\/10.16926\/tiib.2015.03.07.","journal-title":"Pr Nauk Akad Im Jana D\u0142ugosza W Cz\u0119stochowie Tech Inform In\u017c Bezpiecze\u0144stwa"},{"issue":"3","key":"515_CR61","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1128\/AAC.50.3.949-954.2006","volume":"50","author":"M Goswami","year":"2006","unstructured":"Goswami M, Mangoli SH, Jawali N. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother. 2006;50(3):949\u201354. https:\/\/doi.org\/10.1128\/AAC.50.3.949-954.2006.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"515_CR62","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00284-012-0094-7","volume":"64","author":"MM Masadeh","year":"2012","unstructured":"Masadeh MM, Mhaidat NM, Alzoubi KH, Al-Azzam SI, Shaweesh AI. Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C. Curr Microbiol. 2012;64(5):457\u201362. https:\/\/doi.org\/10.1007\/s00284-012-0094-7.","journal-title":"Curr Microbiol"},{"key":"515_CR63","doi-asserted-by":"publisher","DOI":"10.4172\/1948-5948.1000083","author":"E El-Gebaly","year":"2012","unstructured":"El-Gebaly E. Effect of levofloxacin and vitamin C on bacterial adherence and preformed biofilm on urethral catheter surfaces. J Microb Biochem Technol. 2012. https:\/\/doi.org\/10.4172\/1948-5948.1000083.","journal-title":"J. Microb. Biochem. Technol."},{"key":"515_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/nu9040339","author":"H Hemil\u00e4","year":"2017","unstructured":"Hemil\u00e4 H. Vitamin C and infections. Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu9040339.","journal-title":"Nutrients"},{"key":"515_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8573742","author":"L Ran","year":"2020","unstructured":"Ran L, Zhao W, Wang H, Zhao Y, Bu H. Vitamin C as a supplementary therapy in relieving symptoms of the common cold: a meta-analysis of 10 randomized controlled trials. BioMed Res Int. 2020. https:\/\/doi.org\/10.1155\/2020\/8573742.","journal-title":"BioMed Res Int"},{"key":"515_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007020.pub2","author":"L Shamseer","year":"2010","unstructured":"Shamseer L, Adams D, Brown N, Johnson JA, Vohra S. Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2010. https:\/\/doi.org\/10.1002\/14651858.CD007020.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"515_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013134.pub2","author":"ZA Padhani","year":"2020","unstructured":"Padhani ZA, Moazzam Z, Ashraf A, Bilal H, Salam RA, Das JK, Bhutta ZA. Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database Syst Rev. 2020. https:\/\/doi.org\/10.1002\/14651858.CD013134.pub2.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-022-00515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-022-00515-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-022-00515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T01:03:57Z","timestamp":1654131837000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-022-00515-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1186\/s12941-022-00515-5","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"16 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}